Lacunar stroke accounts for 20–25% of all ischemic strokes, resulting from occlusion of a single small penetrating artery (lenticulostriate, thalamogeniculate, basilar perforators) due to lipohyalinosis or microatheroma. [1-2] It is defined as a subcortical infarct <1.5 cm in diameter on CT/MRI, presenting with a classic lacunar syndrome and absence of cortical signs. [3] Despite a relatively favorable short-term prognosis, lacunar stroke carries a 20% recurrence rate and 25% five-year mortality, with significant risk of vascular dementia. [2][4]
1. History
- Onset: Abrupt focal neurological deficit; may have stuttering or stepwise progression over hours (capsular warning syndrome)
- Five classic lacunar syndromes: [4][6-7]
- Pure motor hemiparesis (55%): face, arm, and leg weakness without sensory loss, visual field cut, or aphasia — most common; localizes to posterior limb of internal capsule, corona radiata, or pons [7-8]
- Pure sensory stroke (7%): unilateral numbness/paresthesias without motor deficit — thalamus [8]
- Sensorimotor stroke (20%): combined hemiparesis and hemisensory loss — thalamocapsular junction [7]
- Ataxic hemiparesis (10%): ipsilateral weakness with cerebellar-type ataxia — pons, internal capsule [7]
- Dysarthria–clumsy hand (6%): dysarthria with ipsilateral hand clumsiness — pons, internal capsule [7]
- Key negatives: No aphasia, neglect, visual field deficits, or altered consciousness (absence of cortical signs is a hallmark)
- Timing: Determine last known well (LKW) precisely for thrombolytic eligibility
- Ask about prior TIA, stuttering symptoms, wake-up stroke
2. Alarm Features
- Cortical signs (aphasia, neglect, hemianopia, gaze deviation) → suggests large vessel or cardioembolic stroke, not lacunar
- Rapidly worsening deficit or NIHSS >7 → consider large vessel occlusion or hemorrhagic stroke [9-10]
- Decreased level of consciousness → not typical of lacunar stroke; consider hemorrhage, basilar occlusion, or mass lesion
- Capsular warning syndrome: Repetitive stereotyped motor/sensory episodes heralding completed lacunar infarction — high risk of progression
- Severe headache, vomiting, seizure → atypical; consider hemorrhage or other etiology
3. Medications
- Acute thrombolysis: Alteplase 0.9 mg/kg (max 90 mg; 10% bolus, 90% over 1 hour) within 4.5 hours of LKW, or tenecteplase 0.25 mg/kg (max 25 mg) as a single IV bolus — lacunar stroke is not a contraindication to thrombolysis [11-13]
- Dual antiplatelet therapy (DAPT): For minor stroke (NIHSS ≤5), aspirin + clopidogrel within 24 hours, continued for 21 days, then transition to single antiplatelet [14-15]
- Long-term antiplatelet monotherapy: Aspirin 81 mg daily or clopidogrel 75 mg daily [5][16]
- Antihypertensives: Thiazide diuretics, ACE inhibitors, or ARBs preferred; target <130/80 mmHg [15-16][18]
- Statins: High-intensity statin therapy (e.g., atorvastatin 80 mg); LDL goal <70 mg/dL [6][15]
- Anticoagulation is NOT indicated for lacunar stroke unless a concurrent cardioembolic source (e.g., atrial fibrillation) is identified [3][17]
- Caution: Patients with cerebral small vessel disease and microbleeds have increased bleeding risk on antithrombotics [2][17]
4. Diet
- Low-sodium diet (<2 g/day) for blood pressure control
- Mediterranean or DASH diet recommended for secondary stroke prevention [3][16]
- Adequate hydration to avoid hemoconcentration
- Limit alcohol; avoid binge drinking
- Long-term structured weight-loss program if overweight/obese [15]
5. Review of Systems
- Neurologic: Headache, visual changes, speech difficulty, swallowing difficulty, gait instability, cognitive changes
- Cardiovascular: Palpitations (screen for AF), chest pain, dyspnea, claudication
- Endocrine: Polyuria/polydipsia (undiagnosed diabetes)
- Psychiatric: Depression, apathy (common post-stroke and with small vessel disease) [6]
- Genitourinary: Urinary incontinence (may indicate bilateral lacunar disease)
6. Collateral History and Family History
- Confirm exact time of symptom onset or LKW from witnesses
- Baseline functional status (pre-stroke mRS)
- Medication compliance, especially antihypertensives
- Family history: Hypertension, diabetes, early stroke
- Consider CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) in younger patients with migraine with aura, recurrent lacunar strokes, and family history of early-onset dementia or stroke [15][19]
- Fabry's disease in younger patients with unexplained small vessel disease [19]
7. Risk Factors
- Hypertension — strongest and most specific risk factor for lacunar stroke (OR 2.21 vs. controls) [20-21]
- Diabetes mellitus (OR 2.10) [4][20]
- Hyperlipidemia (OR 1.74) [20]
- Smoking (OR 1.65) [20]
- Chronic kidney disease — associated with white matter hyperintensities and multiple lacunes [20]
- Age (>55 years), male sex [20]
- Pre-existing lacunes or white matter disease on imaging (OR 2.29 for recurrent lacunar infarct) [9][21]
- Obstructive sleep apnea
8. Differential Diagnosis
- Intracerebral hemorrhage — cannot-miss; excluded by NCCT
- Large vessel occlusion stroke — typically NIHSS >7, cortical signs present; CTA needed
- Cardioembolic stroke — may mimic lacunar syndrome in ~5–11% of cases; requires cardiac workup [2][22]
- Branch atheromatous disease — large artery plaque occluding perforator ostia; ~26% of lacunar presentations may have large artery abnormalities [2]
- Hypoglycemia — common stroke mimic; check point-of-care glucose immediately
- Demyelinating disease (MS) — younger patients, MRI distinguishes
- CNS mass lesion/abscess — excluded by imaging
- Todd's paralysis (postictal) — history of seizure
- Migraine with aura — typically younger, gradual onset, positive symptoms
- Conversion disorder/functional neurological disorder — inconsistent exam findings
9. Past Medical History
- Prior stroke or TIA (especially lacunar)
- Hypertension, diabetes, dyslipidemia
- Coronary artery disease, peripheral vascular disease
- Atrial fibrillation or other arrhythmia
- Chronic kidney disease
- Obstructive sleep apnea
- Prior neuroimaging showing white matter hyperintensities, old lacunes, or microbleeds [2][6]
10. Physical Exam
- Vitals: Blood pressure (often elevated; higher SBP associated with lacunar infarcts), heart rate and rhythm, oxygen saturation, temperature, glucose [9-10]
- Neurologic exam (NIHSS): Typically NIHSS <7 (median ~4–5); absence of cortical signs is key [9-10]
- Motor: Unilateral face/arm/leg weakness (proportional involvement)
- Sensory: Unilateral numbness
- Coordination: Limb ataxia out of proportion to weakness (ataxic hemiparesis)
- Speech: Dysarthria without aphasia
- No: Aphasia, neglect, visual field cut, gaze preference, altered consciousness
- Cardiovascular: Irregular rhythm (AF screen), carotid bruits, peripheral pulses
- Fundoscopic: Hypertensive retinopathy (chronic small vessel disease marker)
- Swallow screen before oral intake
11. Lab Studies
- Stat: Point-of-care glucose, CBC, BMP, coagulation studies (PT/INR, aPTT)
- Troponin: Screen for concurrent myocardial injury (elevated in up to 20% of AIS) [23]
- HbA1c: Screen for diabetes/insulin resistance [15][24]
- Fasting lipid panel (nonfasting acceptable acutely) [24]
- Renal function: Creatinine, eGFR (renal impairment associated with worse small vessel disease) [20]
- TSH if clinically indicated
- ESR/CRP: Consider in patients >50 with visual symptoms to rule out giant cell arteritis [24]
- Hypercoagulability workup: Generally not indicated for typical lacunar stroke in older patients with traditional risk factors; consider in younger patients (<50) without clear etiology [19]
12. Imaging
- First-line: Noncontrast CT head — primarily to exclude hemorrhage; sensitivity for acute lacunar infarct is only ~50% [25-26]
- Gold standard: MRI with DWI — highly sensitive (≥70–88%) for acute lacunar infarcts; shows high signal on DWI with corresponding ADC restriction; lesion <1.5 cm in subcortical location [24-25][27]
- Vascular imaging: CTA or MRA of head and neck to exclude large artery stenosis (>50%) and branch atheromatous disease — required to confirm lacunar mechanism [2][27]
- Key MRI findings of small vessel disease: White matter hyperintensities (FLAIR), old lacunes, cerebral microbleeds (SWI/GRE), enlarged perivascular spaces [25][28]
- CT is often normal acutely; a negative CT does not exclude lacunar stroke [25-26]
The following figure illustrates the spectrum of MRI findings in cerebral small vessel disease:
13. Special Tests
- NIHSS: Score typically ≤5; NIHSS <7 combined with OCSP lacunar syndrome classification has 99% specificity for lacunar stroke [9-10]
- ABCD2 score: Useful for TIA risk stratification if symptoms have resolved
- Lacunar Score (NIHSS <7 + OCSP lacunar syndrome): Validated screening tool with NPV 84–90% [10]
- NIHSS discriminating items: Normal language, neglect, visual fields, and no brachial predominance of weakness conveys a 46% probability of lacunar mechanism [29]
- Swallow screening: Bedside swallow assessment before oral intake
14. ECG
- 12-lead ECG on all stroke patients — screen for atrial fibrillation, LVH, ischemic changes [24][30]
- Continuous telemetry for 24–48 hours minimum [31]
- ECG abnormalities (ST changes, QT prolongation, T-wave inversions) are common post-stroke and may represent neurogenic cardiac injury rather than primary cardiac disease [23]
- If no AF detected and stroke mechanism remains uncertain, consider prolonged cardiac monitoring (30-day event monitor or implantable loop recorder) [3][24]
- For confirmed isolated lacunar stroke with clear small vessel disease mechanism, the yield of extensive cardiac workup is low [32]
15. Assessment
- Lacunar stroke is a clinical-radiographic diagnosis: classic lacunar syndrome + subcortical infarct <1.5 cm on MRI + exclusion of large artery and cardioembolic sources [3]
- Severity: Generally mild (NIHSS ≤5); favorable short-term prognosis with ~78% achieving mild or no disability at discharge [4][33]
- Paradoxical course: Good early recovery but significant long-term risk — 4–11% annual recurrence, progressive cognitive decline, vascular dementia [2-3]
- Neurological deterioration occurs in a subset (capsular warning syndrome, early worsening) and is associated with worse outcomes [1]
- ~25% of clinically diagnosed lacunar syndromes may have a nonlacunar mechanism (embolic, large artery) — comprehensive workup is essential [2][22]
16. Treatment Plan
Acute stabilization
- ABCs, IV access, continuous monitoring
- Blood glucose correction (target 140–180 mg/dL; avoid hypoglycemia)
- Blood pressure management: Permissive hypertension (<220/120) if not receiving thrombolysis; if thrombolysis given, maintain <185/110 pre-treatment and <180/105 for 24 hours post-treatment [14]
- NPO until swallow screen completed
Reperfusion therapy
- IV thrombolysis (alteplase or tenecteplase) if within 4.5 hours of LKW and no contraindications — lacunar stroke is eligible; WAKE-UP trial showed no heterogeneity of treatment effect between lacunar and nonlacunar subtypes [12-13]
- Mechanical thrombectomy is generally not applicable (no large vessel occlusion)
- The OPTION trial (2026) demonstrated benefit of tenecteplase for non-large vessel occlusion strokes in the 4.5–24 hour window with salvageable tissue on imaging [34]
Antiplatelet therapy
- If thrombolysis given: hold antiplatelets for 24 hours, then initiate
- Minor stroke (NIHSS ≤5) not receiving thrombolysis: DAPT (aspirin 325 mg load + clopidogrel 300 mg load, then aspirin 81 mg + clopidogrel 75 mg daily) for 21 days → then single antiplatelet [14-15]
Secondary prevention (long-term)
- BP goal <130/80 mmHg (thiazide, ACEi, or ARB preferred) [16][18]
- High-intensity statin (atorvastatin 40–80 mg); LDL goal <70 mg/dL [6][15]
- Diabetes management: Optimize glycemic control
- Lifestyle: Mediterranean/DASH diet, exercise ≥10 min moderate activity 4×/week, smoking cessation, weight management, OSA treatment [3][16]
17. Disposition
- Admit all acute lacunar strokes for monitoring, workup, and secondary prevention initiation — preferably to a stroke unit or monitored bed [24]
- Observation/telemetry for at least 24–48 hours for arrhythmia detection and neurological monitoring [31]
- Neurology consultation (vascular neurology preferred) [24]
- Discharge criteria: Neurologically stable or improving, swallow safe, BP controlled, secondary prevention medications initiated, follow-up arranged
- Transfer to a stroke center if presenting to a facility without neurology or MRI capability
18. Follow Up / Return Precautions
- Follow-up: Neurology within 1–2 weeks; PCP within 2–4 weeks for risk factor optimization [18]
- Outpatient MRI if not obtained during admission
- Prolonged cardiac monitoring if stroke mechanism uncertain
- Return precautions — seek immediate care for:
- New or worsening weakness, numbness, speech difficulty, or vision changes
- Severe headache, confusion, or decreased consciousness
- Difficulty swallowing or breathing
- Expected recovery: Most patients achieve functional independence; motor deficits typically improve over weeks to months
- Counsel on: Medication adherence (antiplatelets, antihypertensives, statins), fall prevention, driving restrictions, depression screening
- Long-term monitoring: Cognitive screening at follow-up visits (vascular cognitive impairment is common with recurrent lacunar disease) [2-3]
References
1. Lacunar Stroke: Mechanisms and Therapeutic Implications. — Yaghi S, Raz E, Yang D, et al. Journal of Neurology, Neurosurgery, and Psychiatry. 2021.
2. Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. — Regenhardt RW, Das AS, Lo EH, Caplan LR. JAMA Neurology. 2018.
3. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. — Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Stroke. 2021.
4. Lacunar Stroke. — Arboix A, Martí-Vilalta JL. Expert Review of Neurotherapeutics. 2009.
5. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel. — Del Brutto VJ, Chaturvedi S, Diener HC, Romano JG, Sacco RL. Journal of the American College of Cardiology. 2019.
6. Small Vessel Disease: Mechanisms and Clinical Implications. — Wardlaw JM, Smith C, Dichgans M. The Lancet. Neurology. 2019.
7. Clinical-Computed Tomographic Correlations of Lacunar Infarction in the Stroke Data Bank. — Chamorro A, Sacco RL, Mohr JP, et al. Stroke. 1991.
8. Diffusion-Weighted MRI in Acute Lacunar Syndromes. A Clinical-Radiological Correlation Study. — Schonewille WJ, Tuhrim S, Singer MB, Atlas SW. Stroke. 1999.
9. Improving Clinical Detection of Acute Lacunar Stroke: Analysis From the IST-3. — Arba F, Mair G, Phillips S, et al. Stroke. 2020.
10. Validation of a Simple Clinical Tool for Screening of Acute Lacunar Stroke-a Substudy of the WAKE-UP Trial. — Arba F, Rinaldi C, Jensen M, et al. International Journal of Stroke : Official Journal of the International Stroke Society. 2024.
11. Stroke. — Hilkens NA, Casolla B, Leung TW, de Leeuw FE. Lancet. 2024.
12. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial. — Barow E, Boutitie F, Cheng B, et al. JAMA Neurology. 2019.
13. Patients With Acute Lacunar Infarction Have Benefit From Intravenous Thrombolysis. — Zivanovic Z, Gubi M, Vlahovic D, et al. Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association. 2019.
14. Acute Ischemic Stroke. — Powers WJ. The New England Journal of Medicine. 2020.
15. Secondary Prevention after Ischemic Stroke. — Furie KL, Kelly PJ. The New England Journal of Medicine. 2026.
16. Recurrent Ischemic Stroke: Prevention Strategies. — Ford B, Dore MM, Koehn TR. American Family Physician. 2026.
17. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review. — Greco A, Occhipinti G, Giacoppo D, et al. Journal of the American College of Cardiology. 2023.
18. Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association. — Kernan WN, Viera AJ, Billinger SA, et al. Stroke. 2021.
19. Aetiological Diagnosis of Ischaemic Stroke in Young Adults. — Ferro JM, Massaro AR, Mas JL. The Lancet. Neurology. 2010.
20. Vascular Risk Factor Profiles Differ Between Magnetic Resonance Imaging-Defined Subtypes of Younger-Onset Lacunar Stroke. — Rutten-Jacobs LCA, Markus HS. Stroke. 2017.
21. Comparison of Risk Factor Between Lacunar Stroke and Large Artery Atherosclerosis Stroke: A Cross-Sectional Study in China. — Lv P, Jin H, Liu Y, et al. PloS One. 2016.
22. Testing the Validity of the Lacunar Hypothesis: The Northern Manhattan Stroke Study Experience. — Gan R, Sacco RL, Kargman DE, et al. Neurology. 1997.
23. Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. — Sposato LA, Hilz MJ, Aspberg S, et al. Journal of the American College of Cardiology. 2020.
24. Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association. — Amin HP, Madsen TE, Bravata DM, et al. Stroke. 2023.
25. Mechanisms of Sporadic Cerebral Small Vessel Disease: Insights From Neuroimaging. — Wardlaw JM, Smith C, Dichgans M. The Lancet. Neurology. 2013.
26. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. — Mendelson SJ, Prabhakaran S. The Journal of the American Medical Association. 2021.
27. Genetic Basis of Lacunar Stroke: A Pooled Analysis of Individual Patient Data and Genome-Wide Association Studies. — Traylor M, Persyn E, Tomppo L, et al. The Lancet. Neurology. 2021.
28. Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review. — Markus HS, van Der Flier WM, Smith EE, et al. JAMA Neurology. 2022.
29. Baseline NIH Stroke Scale Responses Estimate the Probability of Each Particular Stroke Subtype. — Leira EC, Adams HP, Rosenthal GE, Torner JC. Cerebrovascular Diseases. 2008.
30. Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines. — McMahon NE, Bangee M, Benedetto V, et al. Stroke. 2020.
31. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
32. Clinical Utility of the Transthoracic Echocardiogram for Isolated Lacunar Infarcts: A Single-Center Experience. — Nie JZ, Weber MW, Ume K, et al. The Neurologist. 2022.
33. Clinical Study of 227 Patients With Lacunar Infarcts. — Arboix A, Martí-Vilalta JL, García JH. Stroke. 1990.
34. Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke. — Ma G, Mo R, Zuo Y, et al. The Journal of the American Medical Association. 2026.